Home LiteratureArticle Details
PMID: 18568847 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Critical reviews in biochemistry and molecular biology ·Vol. 43 ·No. 3 ·2008-00-00 ·Pages 189-219

White JM, Delos SE, Brecher M, Schornberg K

Abstract

Recent work has identified three distinct classes of viral membrane fusion proteins based on structural criteria. In addition, there are at least four distinct mechanisms by which viral fusion proteins can be triggered to undergo fusion-inducing conformational changes. Viral fusion proteins also contain different types of fusion peptides and vary in their reliance on accessory proteins. These differing features combine to yield a rich diversity of fusion proteins. Yet despite this staggering diversity, all characterized viral fusion proteins convert from a fusion-competent state (dimers or trimers, depending on the class) to a membrane-embedded homotrimeric prehairpin, and then to a trimer-of-hairpins that brings the fusion peptide, attached to the target membrane, and the transmembrane domain, attached to the viral membrane, into close proximity thereby facilitating the union of viral and target membranes. During these conformational conversions, the fusion proteins induce membranes to progress through stages of close apposition, hemifusion, and then the formation of small, and finally large, fusion pores. Clearly, highly divergent proteins have converged on the same overall strategy to mediate fusion, an essential step in the life cycle of every enveloped virus.

MeSH Terms
Animals Cell Membrane/metabolism Humans Hydrogen-Ion Concentration Receptors, Virus/chemistry,metabolism Viral Fusion Proteins/chemistry,genetics,metabolism Virus Internalization
Chemicals
Receptors, Virus Viral Fusion Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
White Judith M
Department of Cell Biology, University of Virginia, Charlottesville, Virginia 22908-0732, USA. jw7g@virginia.edu
Delos Sue E
Brecher Matthew
Schornberg Kathryn
References (298)
298 references, click to expand
  1. HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds.
    Curr Pharm Des. 2007;13(2):143-62 PMID: 17269924
  2. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
    J Cell Biol. 1997 Dec 15;139(6):1455-64 PMID: 9396751
  3. Viral entry.
    Curr Top Microbiol Immunol. 2005;285:1-23 PMID: 15609499
  4. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.
    EMBO J. 2004 Feb 25;23(4):728-38 PMID: 14963486
  5. The entry of entry inhibitors: a fusion of science and medicine.
    Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10598-602 PMID: 12960367
  6. Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement.
    J Virol. 2001 Jun;75(11):5363-9 PMID: 11333918
  7. Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins.
    Virology. 2007 Nov 10;368(1):102-13 PMID: 17655906
  8. Structure of the Ebola fusion peptide in a membrane-mimetic environment and the interaction with lipid rafts.
    J Biol Chem. 2007 Sep 14;282(37):27306-27314 PMID: 17545161
  9. The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells.
    J Virol. 2006 Apr;80(7):3180-8 PMID: 16537586
  10. Signal peptide and helical bundle domains of virulent canine distemper virus fusion protein restrict fusogenicity.
    J Virol. 2007 Oct;81(20):11413-25 PMID: 17686846
  11. A conserved region in the F(2) subunit of paramyxovirus fusion proteins is involved in fusion regulation.
    J Virol. 2007 Aug;81(15):8303-14 PMID: 17507474
  12. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
    FEBS Lett. 2000 Jul 14;477(1-2):145-9 PMID: 10899326
  13. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.
    J Virol. 2003 Jan;77(2):830-40 PMID: 12502799
  14. Human immunodeficiency virus: refolding the envelope.
    Nature. 2005 Feb 24;433(7028):815-6 PMID: 15729327
  15. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.
    J Virol. 1999 Feb;73(2):1419-26 PMID: 9882347
  16. Covalent modifications of the ebola virus glycoprotein.
    J Virol. 2002 Dec;76(24):12463-72 PMID: 12438572
  17. SNAREs--engines for membrane fusion.
    Nat Rev Mol Cell Biol. 2006 Sep;7(9):631-43 PMID: 16912714
  18. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
    J Virol. 2004 Aug;78(15):8201-9 PMID: 15254191
  19. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.
    Virology. 2006 Jul 5;350(2):358-69 PMID: 16519916
  20. The structural basis of paramyxovirus invasion.
    Trends Microbiol. 2006 Jun;14(6):243-6 PMID: 16678421
  21. Virus membrane-fusion proteins: more than one way to make a hairpin.
    Nat Rev Microbiol. 2006 Jan;4(1):67-76 PMID: 16357862
  22. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.
    J Virol. 2002 May;76(9):4603-11 PMID: 11932425
  23. Palmitoylation of the murine leukemia virus envelope glycoprotein transmembrane subunits.
    Virology. 1996 Jul 1;221(1):87-97 PMID: 8661417
  24. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
    Nature. 1981 Jan 29;289(5796):366-73 PMID: 7464906
  25. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein.
    J Virol. 1998 Apr;72(4):3259-67 PMID: 9525653
  26. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    J Virol. 2000 Aug;74(16):7529-37 PMID: 10906206
  27. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion.
    Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18718-23 PMID: 18003913
  28. Oligomerization, secretion, and biological function of an anchor-free parainfluenza virus type 2 (PI2) fusion protein.
    Virology. 2000 May 10;270(2):368-76 PMID: 10792996
  29. Viral and cellular determinants involved in hepadnaviral entry.
    World J Gastroenterol. 2007 Jan 7;13(1):22-38 PMID: 17206752
  30. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.
    Structure. 2005 May;13(5):803-15 PMID: 15893670
  31. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes.
    J Cell Biol. 1995 Nov;131(3):679-91 PMID: 7593189
  32. Molecular gymnastics at the herpesvirus surface.
    EMBO Rep. 2006 Oct;7(10):1000-5 PMID: 17016458
  33. Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion.
    Eur J Biochem. 2002 Sep;269(17):4342-50 PMID: 12199713
  34. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.
    J Cell Biol. 2003 Oct 27;163(2):363-74 PMID: 14581458
  35. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.
    Mol Biol Cell. 2000 Nov;11(11):3765-75 PMID: 11071905
  36. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
    J Virol. 1995 Dec;69(12):7410-5 PMID: 7494245
  37. Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry.
    Virology. 2006 Jan 5;344(1):17-24 PMID: 16364731
  38. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.
    J Virol. 1997 Oct;71(10):8073-7 PMID: 9311907
  39. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.
    J Virol. 1996 Mar;70(3):1406-14 PMID: 8627657
  40. Cellular entry of HIV: Evaluation of therapeutic targets.
    Curr Pharm Des. 2006;12(16):1963-73 PMID: 16787241
  41. Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry.
    J Virol. 2007 Oct;81(19):10758-68 PMID: 17626088
  42. Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex.
    J Mol Biol. 2006 Jun 30;360(1):45-55 PMID: 16813835
  43. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.
    Cell. 1994 Jan 28;76(2):383-91 PMID: 8293471
  44. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion.
    J Virol. 2006 Jan;80(2):710-22 PMID: 16378974
  45. Dissection of the fusion machine of SARS-coronavirus.
    Adv Exp Med Biol. 2006;581:319-22 PMID: 17037552
  46. Role of the stable signal peptide of Junín arenavirus envelope glycoprotein in pH-dependent membrane fusion.
    J Virol. 2006 Aug;80(15):7775-80 PMID: 16840359
  47. The transmembrane domain and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play a role in membrane fusion.
    J Virol. 2002 Nov;76(21):10708-16 PMID: 12368313
  48. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.
    J Virol. 2001 Oct;75(20):9601-12 PMID: 11559792
  49. Analysis of the pH requirement for membrane fusion of different isolates of the paramyxovirus parainfluenza virus 5.
    J Virol. 2006 Mar;80(6):3071-7 PMID: 16501116
  50. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L.
    Virology. 2006 Mar 15;346(2):251-7 PMID: 16460775
  51. Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion.
    J Biol Chem. 2007 Jun 8;282(23):16899-906 PMID: 17416587
  52. Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41.
    J Virol. 2005 Feb;79(4):2097-107 PMID: 15681412
  53. Involvement of lipids in different steps of the flavivirus fusion mechanism.
    J Virol. 2003 Jul;77(14):7856-62 PMID: 12829825
  54. Alanine substitution of conserved residues in the cytoplasmic tail of herpes simplex virus gB can enhance or abolish cell fusion activity and viral entry.
    Virology. 2006 Mar 1;346(1):229-37 PMID: 16325881
  55. Potent D-peptide inhibitors of HIV-1 entry.
    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16828-33 PMID: 17942675
  56. Pre-transmembrane sequence of Ebola glycoprotein. Interfacial hydrophobicity distribution and interaction with membranes.
    FEBS Lett. 2003 Jan 2;533(1-3):47-53 PMID: 12505157
  57. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.
    Mol Biol Cell. 2003 Mar;14(3):926-38 PMID: 12631714
  58. Host cell cathepsins potentiate Moloney murine leukemia virus infection.
    J Virol. 2007 Oct;81(19):10506-14 PMID: 17634228
  59. Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion.
    J Virol. 2003 Jun;77(12):7067-77 PMID: 12768026
  60. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.
    Mol Biol Cell. 1999 Sep;10(9):2803-15 PMID: 10473628
  61. HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane.
    Immunity. 2008 Jan;28(1):52-63 PMID: 18191596
  62. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.
    J Virol. 2004 Feb;78(4):1873-81 PMID: 14747552
  63. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates.
    J Virol. 2007 Mar;81(6):2995-8 PMID: 17229700
  64. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin.
    J Cell Biol. 1987 Dec;105(6 Pt 2):2887-96 PMID: 2447101
  65. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.
    J Virol. 1999 Oct;73(10):8907-12 PMID: 10482652
  66. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity.
    Cell. 1992 Feb 21;68(4):635-45 PMID: 1739972
  67. Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein.
    J Virol. 2007 Apr;81(7):3130-41 PMID: 17251293
  68. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
    Biochemistry. 2005 Jan 25;44(3):947-58 PMID: 15654751
  69. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.
    Science. 2004 Mar 19;303(5665):1866-70 PMID: 14764887
  70. Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus.
    J Virol. 2005 Nov;79(22):13856-64 PMID: 16254321
  71. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
    Retrovirology. 2006 Dec 04;3:90 PMID: 17144914
  72. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
    Biochim Biophys Acta. 1993 Jan 18;1145(1):124-33 PMID: 8422404
  73. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
    J Virol. 2005 Jan;79(1):106-15 PMID: 15596806
  74. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion.
    J Virol. 2002 Dec;76(23):12300-11 PMID: 12414970
  75. A system for functional analysis of Ebola virus glycoprotein.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9 PMID: 9405687
  76. Structure and membrane interaction of the internal fusion peptide of avian sarcoma leukosis virus.
    Eur J Biochem. 2004 Dec;271(23-24):4725-36 PMID: 15606759
  77. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain.
    Biochemistry. 2005 Dec 13;44(49):16167-80 PMID: 16331977
  78. Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.
    J Virol. 1994 Mar;68(3):1667-74 PMID: 8107227
  79. The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.
    J Virol. 2005 Feb;79(3):1678-85 PMID: 15650193
  80. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.
    Nat Struct Biol. 2001 Aug;8(8):715-20 PMID: 11473264
  81. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.
    Virol J. 2006 Dec 27;3:105 PMID: 17192179
  82. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes).
    Theor Biol Med Model. 2004 Nov 15;1:10 PMID: 15544707
  83. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37.
    J Virol. 1987 May;61(5):1609-14 PMID: 3033286
  84. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus.
    Nature. 2004 Jan 22;427(6972):320-5 PMID: 14737160
  85. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.
    J Cell Biol. 1996 May;133(3):559-69 PMID: 8636231
  86. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.
    Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17903-8 PMID: 17093041
  87. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth.
    Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 PMID: 15937118
  88. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
    Biochemistry. 1994 Mar 22;33(11):3201-9 PMID: 8136355
  89. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.
    J Virol. 2005 Oct;79(19):12132-47 PMID: 16160141
  90. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Virology. 1991 Sep;184(1):445-8 PMID: 1871979
  91. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.
    J Virol. 2000 May;74(10):4474-82 PMID: 10775583
  92. Conformation- and fusion-defective mutations in the hypothetical phospholipid-binding and fusion peptides of viral hemorrhagic septicemia salmonid rhabdovirus protein G.
    J Virol. 2004 Sep;78(17):9115-22 PMID: 15308707
  93. Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity.
    J Virol. 2007 Sep;81(17):9596-600 PMID: 17553877
  94. Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion.
    Biochim Biophys Acta. 2003 Jul 11;1614(1):14-23 PMID: 12873762
  95. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells.
    J Virol. 2003 May;77(9):5324-32 PMID: 12692234
  96. The cell biology of HIV-1 and other retroviruses.
    Retrovirology. 2006 Nov 03;3:77 PMID: 17083721
  97. The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3425-30 PMID: 9520382
  98. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events.
    J Cell Biol. 1996 Oct;135(1):63-71 PMID: 8858163
  99. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
    J Virol. 2005 Mar;79(6):3488-99 PMID: 15731243
  100. Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12386-90 PMID: 12218182
  101. Paramyxovirus fusion: a hypothesis for changes.
    Virology. 1993 Nov;197(1):1-11 PMID: 8212546
  102. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion.
    EMBO J. 2004 Jan 14;23(1):54-65 PMID: 14685283
  103. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
    J Virol. 2007 Apr;81(7):3216-28 PMID: 17229690
  104. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
    J Virol. 2004 Apr;78(7):3429-35 PMID: 15016865
  105. Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement.
    Virology. 2003 Nov 25;316(2):234-44 PMID: 14644606
  106. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles.
    Biochemistry. 2001 Aug 14;40(32):9570-8 PMID: 11583156
  107. Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.
    Antivir Chem Chemother. 2007;18(4):169-89 PMID: 17907376
  108. Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner.
    Biochemistry. 1995 Aug 22;34(33):10319-24 PMID: 7654685
  109. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
    FEBS Lett. 2006 Apr 17;580(9):2395-99 PMID: 16616522
  110. The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection.
    J Virol. 2004 Feb;78(3):1403-10 PMID: 14722295
  111. Common properties of fusion peptides from diverse systems.
    Biosci Rep. 2000 Dec;20(6):483-500 PMID: 11426690
  112. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.
    J Virol. 2002 Jan;76(1):406-10 PMID: 11739705
  113. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.
    J Virol. 1998 Aug;72(8):6537-45 PMID: 9658097
  114. Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.
    J Virol. 2003 Jun;77(11):6520-7 PMID: 12743308
  115. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.
    J Virol. 2008 Mar;82(6):2883-94 PMID: 18199653
  116. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
    J Virol. 2004 Jan;78(2):1026-31 PMID: 14694135
  117. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  118. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
    J Virol. 2007 Aug;81(16):8752-65 PMID: 17537855
  119. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Microbes Infect. 2007 Jan;9(1):1-6 PMID: 17196419
  120. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
    Biochemistry. 2001 Oct 16;40(41):12231-6 PMID: 11591141
  121. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Virology. 1998 Aug 15;248(1):20-34 PMID: 9705252
  122. Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion.
    PLoS One. 2007 Oct 24;2(10):e1082 PMID: 17957264
  123. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
    J Virol. 2000 Oct;74(20):9738-41 PMID: 11000247
  124. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity.
    J Biol Chem. 2006 Mar 3;281(9):5760-70 PMID: 16407195
  125. Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.
    J Virol. 2005 Jul;79(13):8374-87 PMID: 15956582
  126. Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion.
    J Virol. 2005 Sep;79(17):11161-9 PMID: 16103167
  127. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains.
    J Virol. 2002 Apr;76(7):3267-75 PMID: 11884551
  128. Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation.
    J Virol. 2002 Dec;76(24):12405-13 PMID: 12438566
  129. Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex.
    Cell Microbiol. 2008 Jan;10(1):149-64 PMID: 17708756
  130. The C. elegans developmental fusogen EFF-1 mediates homotypic fusion in heterologous cells and in vivo.
    Dev Cell. 2006 Oct;11(4):471-81 PMID: 17011487
  131. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain.
    Virology. 2003 Aug 1;312(2):295-305 PMID: 12919735
  132. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling.
    J Virol. 2007 May;81(9):4520-32 PMID: 17301148
  133. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.
    J Virol. 2006 Jun;80(12):5768-76 PMID: 16731916
  134. The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.
    PLoS One. 2007 Jan 24;2(1):e171 PMID: 17245447
  135. Refinement of the influenza virus hemagglutinin by simulated annealing.
    J Mol Biol. 1990 Apr 20;212(4):737-61 PMID: 2329580
  136. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
    J Virol. 2004 Apr;78(7):3753-62 PMID: 15016895
  137. Fusion of Rous sarcoma virus with host cells does not require exposure to low pH.
    J Virol. 1990 Oct;64(10):5106-13 PMID: 2168989
  138. Multistep regulation of membrane insertion of the fusion peptide of Semliki Forest virus.
    J Virol. 2004 Apr;78(7):3312-8 PMID: 15016852
  139. Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.
    J Virol. 2002 Feb;76(3):1252-64 PMID: 11773401
  140. Leash in the groove mechanism of membrane fusion.
    Nat Struct Biol. 2003 Dec;10(12):1048-53 PMID: 14595397
  141. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
    Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81 PMID: 16081529
  142. Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.
    J Virol. 2005 Jun;79(11):6655-63 PMID: 15890903
  143. Strength of envelope protein interaction modulates cytopathicity of measles virus.
    J Virol. 2002 May;76(10):5051-61 PMID: 11967321
  144. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    J Virol. 2001 Oct;75(20):9925-38 PMID: 11559825
  145. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Virol J. 2005 Jun 01;2:49 PMID: 15927084
  146. The pH independence of mammalian retrovirus infection.
    J Gen Virol. 1990 Apr;71 ( Pt 4):767-73 PMID: 2157795
  147. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ.
    PLoS Pathog. 2006 Aug;2(8):e83 PMID: 16933990
  148. Evidence for a role of the membrane-proximal region of herpes simplex virus type 1 glycoprotein H in membrane fusion and virus inhibition.
    Chembiochem. 2007 May 25;8(8):885-95 PMID: 17458915
  149. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation.
    Nature. 2006 Jan 5;439(7072):38-44 PMID: 16397490
  150. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Nature. 1998 Jun 18;393(6686):648-59 PMID: 9641677
  151. Virus entry: open sesame.
    Cell. 2006 Feb 24;124(4):729-40 PMID: 16497584
  152. Lipids as modulators of membrane fusion mediated by viral fusion proteins.
    Eur Biophys J. 2007 Nov;36(8):887-99 PMID: 17882414
  153. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.
    Virology. 2004 Aug 1;325(2):287-96 PMID: 15246268
  154. The relevance of salt bridges for the stability of the influenza virus hemagglutinin.
    FASEB J. 2007 Apr;21(4):995-1002 PMID: 17218542
  155. Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.
    J Virol. 2000 Jan;74(1):447-55 PMID: 10590134
  156. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.
    J Virol. 2006 Apr;80(8):4174-8 PMID: 16571833
  157. The dynamic envelope of a fusion class II virus. Prefusion stages of semliki forest virus revealed by electron cryomicroscopy.
    J Biol Chem. 2007 Mar 2;282(9):6752-62 PMID: 17192272
  158. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
    J Virol. 2005 Apr;79(7):4347-56 PMID: 15767435
  159. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein.
    J Biol Chem. 2008 Mar 7;283(10):6418-27 PMID: 18165228
  160. Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy.
    Biochemistry. 2006 Oct 31;45(43):12960-75 PMID: 17059213
  161. A critical evaluation of the conformational requirements of fusogenic peptides in membranes.
    Eur Biophys J. 2007 Apr;36(4-5):405-13 PMID: 17089152
  162. A novel role for phagocytosis-like uptake in herpes simplex virus entry.
    J Cell Biol. 2006 Sep 25;174(7):1009-21 PMID: 17000878
  163. An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.
    J Mol Biol. 2007 Nov 16;374(1):64-79 PMID: 17920626
  164. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8967-72 PMID: 10430879
  165. Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.
    Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17474-9 PMID: 15583133
  166. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein.
    J Virol. 2005 Oct;79(20):12714-20 PMID: 16188974
  167. Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.
    J Virol. 2007 Nov;81(22):12515-24 PMID: 17804515
  168. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
    Proc Natl Acad Sci U S A. 2007 May 15;104(20):8467-71 PMID: 17483482
  169. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
    Science. 2005 Jun 10;308(5728):1643-5 PMID: 15831716
  170. Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure.
    J Virol. 2000 Jul;74(14):6614-21 PMID: 10864675
  171. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions.
    Virology. 1991 Dec;185(2):875-8 PMID: 1660205
  172. Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein.
    J Virol. 2004 Dec;78(23):13053-61 PMID: 15542657
  173. Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5.
    J Virol. 2002 Sep;76(18):9284-97 PMID: 12186912
  174. Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion.
    J Virol. 2005 Sep;79(18):12065-76 PMID: 16140782
  175. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
    J Virol. 2005 Oct;79(19):12231-41 PMID: 16160149
  176. A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion.
    J Virol. 2004 Jan;78(1):473-81 PMID: 14671127
  177. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
    Nat Med. 1998 Nov;4(11):1302-7 PMID: 9809555
  178. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.
    J Virol. 1998 Mar;72(3):1775-81 PMID: 9499027
  179. Structure of influenza haemagglutinin at the pH of membrane fusion.
    Nature. 1994 Sep 1;371(6492):37-43 PMID: 8072525
  180. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
    Biochemistry. 2006 Dec 26;45(51):15768-75 PMID: 17176099
  181. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
    J Biol Chem. 1997 May 23;272(21):13496-505 PMID: 9153194
  182. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
    J Virol. 1999 Mar;73(3):2469-80 PMID: 9971832
  183. Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency.
    J Virol. 2008 Mar;82(6):3131-4 PMID: 18184714
  184. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.
    J Mol Biol. 2004 Jan 30;335(5):1343-57 PMID: 14729348
  185. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.
    J Virol. 1998 Apr;72(4):3155-60 PMID: 9525641
  186. Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.
    J Virol. 2006 Apr;80(8):3773-80 PMID: 16571794
  187. Membranes of the world unite!
    J Cell Biol. 2006 Oct 23;175(2):201-7 PMID: 17043140
  188. Protein folding in membranes: determining energetics of peptide-bilayer interactions.
    Methods Enzymol. 1998;295:62-87 PMID: 9750214
  189. Deacylation of the transmembrane domains of Sindbis virus envelope glycoproteins E1 and E2 does not affect low-pH-induced viral membrane fusion activity.
    FEBS Lett. 2001 Jun 1;498(1):57-61 PMID: 11389898
  190. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion.
    J Virol. 2004 Apr;78(7):3733-41 PMID: 15016893
  191. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    J Virol. 2001 Jun;75(11):5263-76 PMID: 11333908
  192. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH.
    J Virol. 2006 Nov;80(22):10931-41 PMID: 16971452
  193. The central proline of an internal viral fusion peptide serves two important roles.
    J Virol. 2000 Feb;74(4):1686-93 PMID: 10644338
  194. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.
    Virology. 2007 Apr 10;360(2):264-74 PMID: 17134730
  195. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.
    Mol Biol Cell. 1999 Aug;10(8):2759-69 PMID: 10436026
  196. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    J Virol. 2004 Dec;78(24):13430-9 PMID: 15564453
  197. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system.
    Virology. 2000 Mar 30;269(1):37-46 PMID: 10725196
  198. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement.
    J Membr Biol. 2004 May 1;199(1):1-14 PMID: 15366419
  199. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
    J Virol. 2004 Oct;78(19):10724-37 PMID: 15367639
  200. The Role of histidine residues in low-pH-mediated viral membrane fusion.
    Structure. 2006 Oct;14(10):1481-7 PMID: 17027497
  201. The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry.
    Virology. 2004 Mar 1;320(1):156-66 PMID: 15003871
  202. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B.
    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2903-8 PMID: 17299053
  203. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.
    Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):13938-43 PMID: 16963566
  204. A conserved region between the heptad repeats of paramyxovirus fusion proteins is critical for proper F protein folding.
    Biochemistry. 2007 May 1;46(17):5094-105 PMID: 17417875
  205. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  206. The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase.
    Virology. 2007 Apr 25;361(1):149-60 PMID: 17182074
  207. Flavivirus membrane fusion.
    J Gen Virol. 2006 Oct;87(Pt 10):2755-2766 PMID: 16963734
  208. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity.
    J Virol. 2003 Dec;77(23):12807-18 PMID: 14610202
  209. In vivo tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not full-length orfX open reading frame.
    Virology. 2007 Oct 25;367(2):413-21 PMID: 17610928
  210. Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation.
    J Virol. 2006 Oct;80(19):9921-5 PMID: 16973599
  211. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.
    J Cell Biol. 2000 Oct 16;151(2):425-37 PMID: 11038188
  212. Capture of an early fusion-active conformation of HIV-1 gp41.
    Nat Struct Biol. 1998 Apr;5(4):276-9 PMID: 9546217
  213. Mechanism of membrane fusion by viral envelope proteins.
    Adv Virus Res. 2005;64:231-61 PMID: 16139596
  214. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.
    J Virol. 2007 Oct;81(20):10879-89 PMID: 17670830
  215. Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B.
    Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13140-5 PMID: 17666526
  216. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
    J Cell Biol. 2000 Oct 16;151(2):413-23 PMID: 11038187
  217. Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites.
    J Virol. 2003 Feb;77(3):1666-71 PMID: 12525600
  218. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.
    Mol Cell. 2001 Mar;7(3):593-602 PMID: 11463384
  219. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein.
    J Virol. 2007 Sep;81(18):9900-10 PMID: 17626104
  220. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.
    Virology. 2007 Jun 5;362(2):468-74 PMID: 17303204
  221. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.
    J Virol. 1999 Jul;73(7):6089-92 PMID: 10364363
  222. Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein.
    FEBS Lett. 2004 Jul 2;569(1-3):261-6 PMID: 15225645
  223. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion.
    J Cell Biol. 2005 Oct 10;171(1):111-20 PMID: 16216925
  224. Functional interaction between paramyxovirus fusion and attachment proteins.
    J Biol Chem. 2008 Jun 13;283(24):16561-72 PMID: 18426797
  225. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.
    Virology. 2008 Jan 20;370(2):403-14 PMID: 17936324
  226. Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide.
    J Virol. 2004 Feb;78(4):2131-6 PMID: 14747578
  227. Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity.
    J Cell Biol. 1998 Jun 15;141(6):1335-47 PMID: 9628890
  228. Chemical shift assignment and structural plasticity of a HIV fusion peptide derivative in dodecylphosphocholine micelles.
    Biochim Biophys Acta. 2007 Dec;1768(12):3225-34 PMID: 17935693
  229. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
    J Virol. 2001 Nov;75(22):11096-105 PMID: 11602749
  230. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.
    J Virol. 1994 Jan;68(1):570-4 PMID: 8254774
  231. VSV transmembrane domain (TMD) peptide promotes PEG-mediated fusion of liposomes in a conformationally sensitive fashion.
    Biochemistry. 2002 Dec 17;41(50):14925-34 PMID: 12475241
  232. Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity.
    Virology. 2001 Feb 1;280(1):52-61 PMID: 11162818
  233. Mapping the landscape of the lymphocytic choriomeningitis virus stable signal peptide reveals novel functional domains.
    J Virol. 2007 Jun;81(11):5649-57 PMID: 17376927
  234. Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differences in viral infectivity.
    J Virol. 2003 Feb;77(3):1977-83 PMID: 12525631
  235. Virus membrane fusion.
    FEBS Lett. 2007 May 22;581(11):2150-5 PMID: 17320081
  236. Cryo-electron microscopy reveals the functional organization of an enveloped virus, Semliki Forest virus.
    Mol Cell. 2000 Feb;5(2):255-66 PMID: 10882067
  237. Detection of cell-cell fusion mediated by Ebola virus glycoproteins.
    J Virol. 2006 Mar;80(6):2815-22 PMID: 16501090
  238. Structure and function of a paramyxovirus fusion protein.
    Biochim Biophys Acta. 2003 Jul 11;1614(1):73-84 PMID: 12873767
  239. Cell-to-cell fusion as a link between viruses and cancer.
    Nat Rev Cancer. 2007 Dec;7(12):968-76 PMID: 18034186
  240. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity.
    J Virol. 2005 May;79(10):6449-58 PMID: 15858028
  241. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
    J Virol. 2007 Dec;81(24):13378-84 PMID: 17928356
  242. Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage.
    J Biol Chem. 2001 Jan 12;276(2):1391-7 PMID: 11027678
  243. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
    Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7 PMID: 16116101
  244. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
    J Virol. 2003 May;77(10):5829-36 PMID: 12719576
  245. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    J Virol. 2001 Jul;75(14):6635-44 PMID: 11413331
  246. Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity.
    J Gen Virol. 2007 Aug;88(Pt 8):2320-2328 PMID: 17622638
  247. The many mechanisms of viral membrane fusion proteins.
    Curr Top Microbiol Immunol. 2005;285:25-66 PMID: 15609500
  248. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review).
    Mol Membr Biol. 1997 Jul-Sep;14(3):97-112 PMID: 9394290
  249. Class II virus membrane fusion proteins.
    Virology. 2006 Jan 5;344(1):38-47 PMID: 16364734
  250. Receptor-induced conformational changes of murine coronavirus spike protein.
    J Virol. 2002 Dec;76(23):11819-26 PMID: 12414924
  251. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G.
    Science. 2007 Feb 9;315(5813):843-8 PMID: 17289996
  252. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion.
    EMBO J. 2001 Aug 1;20(15):4024-34 PMID: 11483506
  253. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.
    Biochemistry. 1990 Aug 28;29(34):7917-22 PMID: 2261447
  254. Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B.
    J Virol. 2007 May;81(9):4858-65 PMID: 17314168
  255. The p14 fusion-associated small transmembrane (FAST) protein effects membrane fusion from a subset of membrane microdomains.
    J Biol Chem. 2006 Oct 20;281(42):31778-89 PMID: 16936325
  256. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Annu Rev Biochem. 2000;69:531-69 PMID: 10966468
  257. Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers.
    Biophys J. 2007 Aug 1;93(3):876-85 PMID: 17513369
  258. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
    Virology. 1997 Aug 18;235(1):118-28 PMID: 9300043
  259. Structural basis of viral invasion: lessons from paramyxovirus F.
    Curr Opin Struct Biol. 2007 Aug;17(4):427-36 PMID: 17870467
  260. Membrane hemifusion: crossing a chasm in two leaps.
    Cell. 2005 Nov 4;123(3):375-82 PMID: 16269330
  261. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
    Mol Biol Cell. 2000 Apr;11(4):1143-52 PMID: 10749920
  262. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G.
    Science. 2006 Jul 14;313(5784):187-91 PMID: 16840692
  263. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.
    Science. 2007 Sep 28;317(5846):1930-4 PMID: 17901336
  264. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Cell. 2007 Apr 20;129(2):263-75 PMID: 17448989
  265. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.
    Nat Struct Biol. 2000 Nov;7(11):1068-74 PMID: 11062565
  266. Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.
    J Virol. 2004 Nov;78(21):11536-43 PMID: 15479794
  267. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.
    J Virol. 2007 Jun;81(12):6286-93 PMID: 17409143
  268. Structure of an unliganded simian immunodeficiency virus gp120 core.
    Nature. 2005 Feb 24;433(7028):834-41 PMID: 15729334
  269. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.
    EMBO J. 2005 Dec 7;24(23):4144-53 PMID: 16292345
  270. The HIV Env-mediated fusion reaction.
    Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50 PMID: 12873764
  271. Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus.
    Antioxid Redox Signal. 2007 Aug;9(8):1009-34 PMID: 17567241
  272. Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion.
    Biochemistry. 2007 Feb 6;46(5):1398-401 PMID: 17260969
  273. The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH.
    Cell. 2001 Apr 6;105(1):137-48 PMID: 11301009
  274. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
    J Virol. 2003 Mar;77(5):3058-66 PMID: 12584331
  275. Entry of duck hepatitis B virus into primary duck liver and kidney cells after discovery of a fusogenic region within the large surface protein.
    J Virol. 2007 May;81(10):5014-23 PMID: 17360753
  276. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    J Virol. 1992 Aug;66(8):4940-50 PMID: 1629960
  277. The protein coat in membrane fusion: lessons from fission.
    Traffic. 2002 Apr;3(4):256-67 PMID: 11929607
  278. A stiffness switch in human immunodeficiency virus.
    Biophys J. 2007 Mar 1;92(5):1777-83 PMID: 17158573
  279. Mechanisms of viral membrane fusion and its inhibition.
    Annu Rev Biochem. 2001;70:777-810 PMID: 11395423
  280. Distribution and three-dimensional structure of AIDS virus envelope spikes.
    Nature. 2006 Jun 15;441(7095):847-52 PMID: 16728975
  281. Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion.
    J Biol Chem. 2007 Aug 10;282(32):23104-16 PMID: 17526486
  282. Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization.
    J Virol. 2004 Mar;78(6):3178-83 PMID: 14990739
  283. Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes.
    J Biol Chem. 2002 Oct 11;277(41):38141-7 PMID: 12138173
  284. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein.
    Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93 PMID: 15964978
  285. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain.
    J Virol. 2006 Jul;80(14):6794-800 PMID: 16809285
  286. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Nature. 1995 May 25;375(6529):291-8 PMID: 7753193
  287. Crystal structure of glycoprotein B from herpes simplex virus 1.
    Science. 2006 Jul 14;313(5784):217-20 PMID: 16840698
  288. Receptor-triggered membrane association of a model retroviral glycoprotein.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 PMID: 9482929
  289. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.
    J Virol. 2006 May;80(10):4878-89 PMID: 16641279
  290. A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion.
    J Virol. 2004 Dec;78(24):13543-52 PMID: 15564465
  291. Reversibility in fusion protein conformational changes. The intriguing case of rhabdovirus-induced membrane fusion.
    Subcell Biochem. 2000;34:379-408 PMID: 10808339
  292. Locking the kink in the influenza hemagglutinin fusion domain structure.
    J Biol Chem. 2007 Aug 17;282(33):23946-56 PMID: 17567572
  293. HIV entry inhibitors.
    Lancet. 2007 Jul 7;370(9581):81-8 PMID: 17617275
  294. Effects of double-site mutations of vesicular stomatitis virus glycoprotein G on membrane fusion activity.
    Virology. 1999 Mar 30;256(1):119-29 PMID: 10087232
  295. Single event recording shows that docking onto receptor alters the kinetics of membrane fusion mediated by influenza hemagglutinin.
    Biophys J. 1993 Jul;65(1):171-6 PMID: 8369426
  296. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
    J Virol. 1998 Dec;72(12):9955-65 PMID: 9811733
  297. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly.
    J Virol. 2005 Nov;79(21):13673-84 PMID: 16227287
  298. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.
    Cell. 2000 Nov 10;103(4):679-89 PMID: 11106737
Article Info
Journal
Critical reviews in biochemistry and molecular biology
Abbr.
Crit Rev Biochem Mol Biol
ISSN
1549-7798
Published
2008-00-00
Pages
189-219
Language
English
Region
England
NLM ID
8903774
PMCID
PMC2649671
Subset
IM
Grants
NIAID NIH HHS · AI22470 · United States
NIAID NIH HHS · R21AI055925 · United States
NIAID NIH HHS · R01 AI022470 · United States
NIAID NIH HHS · R21 AI055925 · United States
NIAID NIH HHS · U54 AI57168 · United States
NIAID NIH HHS · R01 AI022470-24 · United States
NIAID NIH HHS · T32 AI007046 · United States
NIAID NIH HHS · U54 AI057168-05S20021 · United States
NIAID NIH HHS · U54 AI057168 · United States
NIAID NIH HHS · T32 AI055432 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com